Stories of 5 Biotypes — a compilation of published cases

Before

M. (37) is an IT manager, mother of two young children. Five years of chronic anxiety and exhaustion. Her psychiatrist prescribed SSRIs and benzodiazepines — the first SSRI helped for a few months, then stopped working. The second SSRI made her worse. Her doctor added a third as an augmentation strategy.

All standard blood tests came back "within range." Thyroid fine. Iron fine. Vitamin D supplemented. Her doctor told her she had "treatment-resistant depression" and suggested electroconvulsive therapy.

Testing and intervention

After reading Walsh's book Nutrient Power, she had a pyroluria test (morning urine) done at an orthomolecular clinic. Result: markedly elevated pyrrole molecules. Blood histamine normal. A classic type 1 presentation.

Course (12 months)

• After several weeks of targeted nutritional support, she reported: for the first time since childhood, she remembered her dreams, and morning anxiety was noticeably milder.
• After 4 months: she discontinued her benzodiazepine in coordination with her doctor. Her SSRI dose was gradually reduced. Better sleep, better stress tolerance, return of libido.
• After 12 months: she returned to work.
• In several published cases, medication use was gradually reduced over a longer period (months to more than a year) — always exclusively in coordination with the treating physician, and with individually different outcomes. This is not a promise or a typical result.

Before

P. (44) is an engineer. A classic "high-functioning depressive." He remembers performance pressure, perfectionism and obsessive thinking since youth. Seasonal allergies. Family history includes both alcoholism and exceptional academic achievement.

He was put on an SSRI as a young man. It helped. Stable for about 10 years. Then a naturopath decided to add methylfolate (5-MTHF) at 1 mg daily "for better results."

Three weeks later — the worst depression of his life. Suicidal thoughts. Two weeks of hospitalization. No one knew what had happened.

Testing and intervention

After discharge he sought out a doctor trained in the orthomolecular approach. Blood histamine: 95 ng/ml (normal range 40–70) — classic histadelia. Folate had raised SERT activity and pushed his already-low functional serotonin even lower.

Course (18 months)

• After discontinuing folate and starting targeted nutritional support (calcium, methionine), his condition improved noticeably within a few weeks.
• After 6 months: anxiety and obsessive thinking milder, the ability to feel enjoyment returned.
• After 18 months: stable.
• In several published cases, medication use was gradually reduced over a longer period (months to more than a year) — always exclusively in coordination with the treating physician, and with individually different outcomes. This is not a promise or a typical result.

Before

L. (29) is a graphic designer. Panic attacks since adolescence, high anxiety, intolerance of loud places, chemical sensitivities (perfumes, cleaning products). Dry eyes and mouth. No seasonal allergies. History of eczema.

Her psychiatrist started sertraline (an SSRI). After a week: panic tripled in severity. A benzodiazepine was added. Other SSRIs were tried. All of them made things worse.

Her doctor suggested "trying" lithium. That brought some improvement. But L. understood that lithium works as an anti-glutamate agent, and she knew her presentation wasn't bipolar.

Testing and intervention

After studying the orthomolecular approach, she switched to an orthomolecular physician. Blood histamine: 28 ng/ml (normal range 40–70) — markedly low. Classic histapenia. She started targeted nutritional support (niacin/B3, folate as 5-MTHF, B12, L-tryptophan).

Course (14 months)

• After 8 weeks: panic attacks noticeably less frequent. Better sleep.
• After 6 months: anxiety easier to manage, chemical sensitivity milder, renewed interest in her hobbies.
• In several published cases, medication use was gradually reduced over a longer period (months to more than a year) — always exclusively in coordination with the treating physician, and with individually different outcomes. This is not a promise or a typical result.

Before

J. (34) — postpartum depression after her second child. She handled her first child fine. After the second: three months of insomnia, panic attacks, anxious depression, an inability to feel joy toward her baby.

Her psychiatrist started escitalopram. No result. Added sertraline. Her condition worsened. She began having suicidal thoughts.

Her doctor suggested electroconvulsive therapy. Jana declined and kept looking.

Testing and intervention

Through an orthomolecular physician she had serum copper and zinc plus a saliva cortisol profile tested. Free copper markedly elevated, zinc at the low end, cortisol curve completely disrupted (morning hypotension, evening spikes).

Course (9 months)

• After 3 weeks of targeted nutritional support for zinc, B6 and adrenal function (starting dose gradually increased to a maintenance dose): her first uninterrupted nights of sleep.
• After 3 months: gradual tapering of her SSRI in coordination with her doctor. Return of emotional connection with her child.
• After 9 months: free copper within normal range. She returned to work part-time.
• In several published cases, medication use was gradually reduced over a longer period (months to more than a year) — always exclusively in coordination with the treating physician, and with individually different outcomes. This is not a promise or a typical result.

Before

T. (41) — owner of a construction company. Three years of worsening problems: brain fog, memory issues, chemical sensitivities (perfumes, cleaning products), fatigue, skin reactions.

Blood tests "fine." Thyroid within range. A standard blood heavy-metals panel came back negative.

It began shortly after he spent 8 months renovating an old house from the 1950s (lead paint, asbestos exposed while opening up walls).

Testing and intervention

Through an orthomolecular physician he had a hair tissue mineral analysis (HTMA) done. Result: markedly elevated lead, mercury and cadmium. Zinc and magnesium depleted. A classic biotype 5 — toxic overload with metallothionein deficiency.

Course (14 months)

• A gradual, supervised detoxification protocol: zinc, selenium, vitamin C, glutathione, NAC and targeted nutritional support.
• After 6 months: brain fog noticeably lighter, memory improved.
• After 14 months: a repeat HTMA — metal levels within normal ranges. Chemical sensitivities markedly reduced.
• In several published cases, medication use was gradually reduced over a longer period (months to more than a year) — always exclusively in coordination with the treating physician, and with individually different outcomes. This is not a promise or a typical result.